Oxford BioMedica PLC Net Asset Momentum
Oxford BioMedica PLC net asset momentum. Oxford BioMedica PLC (OXB) recorded a net asset momentum of -22.3% as of December 2024, with net assets of GBX60.49 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Oxford BioMedica PLC (OXB) shareholders funds for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Oxford BioMedica PLC (1996–2024)
Net asset momentum of Oxford BioMedica PLC from 1996 to 2024. This chart tracks Oxford BioMedica PLC's year-over-year net asset growth across 30 annual reporting periods from 1996 to 2024. The most recent momentum reading is -22.3%, with net assets of GBX60.49 Million GBX as of December 2024. Check OXB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Oxford BioMedica PLC Net Asset Momentum by Year (1996–2024)
Oxford BioMedica PLC net asset momentum by year from 1996 to 2024. The table below shows the complete annual net asset history for Oxford BioMedica PLC from 1996 to 2024, covering 30 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see OXB stock market capitalisation.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | GBX60.49 Million | GBX231.64 Million | GBX171.16 Million | ▼ -22.3% |
| 2023 | GBX77.83 Million | GBX252.34 Million | GBX174.51 Million | ▼ -67.0% |
| 2022 | GBX236.19 Million | GBX460.18 Million | GBX223.99 Million | ▲ +26.1% |
| 2021 | GBX187.34 Million | GBX237.23 Million | GBX49.89 Million | ▲ +66.2% |
| 2020 | GBX112.75 Million | GBX183.93 Million | GBX71.18 Million | ▲ +49.1% |
| 2019 | GBX75.63 Million | GBX122.93 Million | GBX47.30 Million | ▲ +117.7% |
| 2018 | GBX34.74 Million | GBX112.40 Million | GBX77.66 Million | ▲ +465.3% |
| 2017 | GBX6.15 Million | GBX65.40 Million | GBX59.26 Million | ▼ -51.3% |
| 2016 | GBX12.62 Million | GBX56.94 Million | GBX44.33 Million | ▲ +15.8% |
| 2015 | GBX10.89 Million | GBX51.85 Million | GBX40.96 Million | ▼ -52.7% |
| 2014 | GBX23.04 Million | GBX33.80 Million | GBX10.77 Million | ▲ +158.9% |
| 2013 | GBX8.90 Million | GBX13.64 Million | GBX4.75 Million | ▼ -54.7% |
| 2012 | GBX19.64 Million | GBX24.42 Million | GBX4.78 Million | ▲ +10.5% |
| 2011 | GBX17.77 Million | GBX26.09 Million | GBX8.32 Million | ▲ +53.1% |
| 2010 | GBX11.61 Million | GBX25.64 Million | GBX14.04 Million | ▼ -44.7% |
| 2009 | GBX20.98 Million | GBX43.95 Million | GBX22.97 Million | ▼ -9.9% |
| 2008 | GBX23.27 Million | GBX43.12 Million | GBX19.85 Million | ▼ -27.1% |
| 2007 | GBX31.93 Million | GBX61.16 Million | GBX29.23 Million | ▲ +6.1% |
| 2006 | GBX30.09 Million | GBX35.54 Million | GBX5.45 Million | ▼ -35.4% |
| 2005 | GBX46.60 Million | GBX49.24 Million | GBX2.64 Million | ▲ +76.7% |
| 2004 | GBX26.38 Million | GBX28.58 Million | GBX2.21 Million | ▼ -25.1% |
| 2003 | GBX35.21 Million | GBX36.71 Million | GBX1.50 Million | ▲ +37.9% |
| 2002 | GBX25.53 Million | GBX26.79 Million | GBX1.26 Million | ▼ -31.9% |
| 2001 | GBX37.51 Million | GBX39.26 Million | GBX1.76 Million | ▲ +189.0% |
| 2000 | GBX12.98 Million | GBX14.32 Million | GBX1.34 Million | ▲ +241.4% |
| 1999 | GBX3.80 Million | GBX4.60 Million | GBX801.00K | ▼ -20.2% |
| 1998 | GBX4.76 Million | GBX5.24 Million | GBX480.00K | ▲ +72.4% |
| 1997 | GBX2.76 Million | GBX3.20 Million | GBX441.00K | ▲ +145.4% |
| 1996 | GBX1.12 Million | GBX1.25 Million | GBX126.00K | ▲ +0.0% |
| 1996 | GBX1.12 Million | GBX1.25 Million | GBX126.00K | — |